9jvw: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "9jvw" [edit=sysop:move=sysop] |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Overall structure of human EAAT2 bound with inhibitor (WAY-213613)== | |||
<StructureSection load='9jvw' size='340' side='right'caption='[[9jvw]], [[Resolution|resolution]] 3.41Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[9jvw]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9JVW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9JVW FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.41Å</td></tr> | |||
[[Category: | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=GJ0:(2~{S})-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl)phenoxy]phenyl]amino]-4-oxidanylidene-butanoic+acid'>GJ0</scene></td></tr> | ||
[[Category: | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9jvw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9jvw OCA], [https://pdbe.org/9jvw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9jvw RCSB], [https://www.ebi.ac.uk/pdbsum/9jvw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9jvw ProSAT]</span></td></tr> | ||
[[Category: | </table> | ||
[[Category: | == Disease == | ||
[[Category: | [https://www.uniprot.org/uniprot/EAA2_HUMAN EAA2_HUMAN] Non-specific early-onset epileptic encephalopathy. The disease is caused by variants affecting the gene represented in this entry. | ||
[[Category: | == Function == | ||
[https://www.uniprot.org/uniprot/EAA2_HUMAN EAA2_HUMAN] Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:14506254, PubMed:15265858, PubMed:26690923, PubMed:7521911). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:14506254). Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport (PubMed:14506254). Essential for the rapid removal of released glutamate from the synaptic cleft, and for terminating the postsynaptic action of glutamate (By similarity).[UniProtKB:P43006]<ref>PMID:15265858</ref> <ref>PMID:26690923</ref> <ref>PMID:7521911</ref> | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | |||
[[Category: Large Structures]] | |||
[[Category: Huang J]] | |||
[[Category: Shi Y]] | |||
[[Category: Xia LY]] | |||
[[Category: Zhang YY]] | |||
[[Category: Zhou Q]] | |||
Latest revision as of 10:37, 30 April 2025
Overall structure of human EAAT2 bound with inhibitor (WAY-213613)
| ||||||||||||
